D. Bandyopadhyay

发表

High levels of expression of p27KIP1 and cyclin E in invasive primary malignant melanomas.

E. Medrano, I. Orengo, C. Dietrich, 1999, The Journal of investigative dermatology.

Marked impairment of protein tyrosine phosphatase 1B activity in adipose tissue of obese subjects with and without type 2 diabetes mellitus.

D. Bandyopadhyay, M. Bryer-Ash, A. Cheung, 1999, The Journal of laboratory and clinical medicine.

Protein-Tyrosine Phosphatase 1B Complexes with the Insulin Receptor in Vivo and Is Tyrosine-phosphorylated in the Presence of Insulin*

J. Chernoff, D. Bandyopadhyay, J. Kusari, 1997, The Journal of Biological Chemistry.

Analysis of Cellular Senescence in Culture In Vivo: The Senescence‐Associated β‐Galactosidase Assay

L. Donehower, E. Medrano, D. Bandyopadhyay, 2005, Current protocols in cell biology.

Cytoplasmic localization of the oncogenic protein Ski in human cutaneous melanomas in vivo: functional implications for transforming growth factor beta signaling.

E. Medrano, W. Xu, E. Bales, 2001, Cancer research.

Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes.

P. Cole, E. Medrano, E. Bales, 2002, Cancer research.

The human melanocyte: a model system to study the complexity of cellular aging and transformation in non-fibroblastic cells

T. Suwa, J. Campisi, E. Medrano, 2001, Experimental Gerontology.

Discovery of Orally Active, Potent, and Selective Benzotriazole‐Based PTP1B Inhibitors

D. Bandyopadhyay, H. Patel, Mukul R Jain, 2011, ChemMedChem.

Overexpression of Histone Deacetylase 1 Confers Resistance to Sodium Butyrate–Mediated Apoptosis in Melanoma Cells through a p53-Mediated Pathway

E. Medrano, D. Bandyopadhyay, A. Mishra, 2004, Cancer Research.

Discovery of diaminopyrimidine-carboxamide derivatives as JAK3 inhibitors.

D. Bandyopadhyay, H. Patel, R. Bahekar, 2020, Bioorganic chemistry.

ZYKR1, a novel, potent, and peripherally selective kappa opioid receptor agonist reduces visceral pain and pruritus in animal models.

D. Bandyopadhyay, P. Patel, Mukul R Jain, 2022, European journal of pharmacology.

Discovery of 1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-ones based novel, potent and PI3Kδ selective inhibitors.

D. Bandyopadhyay, R. Bahekar, Dipam N Patel, 2019, Bioorganic & medicinal chemistry letters.

Design, synthesis and biological evaluation of γ-lactam hydroxamate based TACE inhibitors

D. Bandyopadhyay, H. Patel, Mukul R Jain, 2011 .

The low molecular weight cyclin E isoforms augment angiogenesis and metastasis of human melanoma cells in vivo.

J. J. van den Oord, K. Keyomarsi, M. Bar‐eli, 2005, Cancer research.

Inhibition of the protein kinase C pathway promotes anti-CD95-induced apoptosis in Jurkat T cells.

L. Drew, S. Gupta, D. Bandyopadhyay, 1998, International immunology.

Inhibition of the protein kinase C pathway promotes anti-CD 95-induced apoptosis in Jurkat T cells

L. Drew, Rakesh Kumar, D. Bandyopadhyay, 1998 .

ZYBT1, a potent, irreversible Bruton’s Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer

D. Bandyopadhyay, Rajiv Sharma, N. Srinivas, 2020, Pharmacology research & perspectives.

Down-Regulation of p 300 / CBP Histone Acetyltransferase Activates a Senescence Checkpoint in Human Melanocytes 1

P. Cole, E. Medrano, E. Bales, 2002 .

Discovery of novel, potent and orally efficacious inhibitor of neutral amino acid transporter B0AT1 (SLC6A19).

Sanjay Kumar, D. Bandyopadhyay, Rajiv Sharma, 2021, Bioorganic & medicinal chemistry letters.

Melanin Accumulation Accelerates Melanocyte Senescence by a Mechanism Involving p16INK4a/CDK4/pRB and E2F1

E. Medrano, D. Bandyopadhyay, 2000, Annals of the New York Academy of Sciences.

The emerging role of epigenetics in cellular and organismal aging

E. Medrano, D. Bandyopadhyay, 2003, Experimental Gerontology.

Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi

E. Medrano, D. Bandyopadhyay, P. Hornsby, 2007, Aging cell.

Discovery of a potent G-protein-coupled receptor 119 agonist for the treatment of type 2 diabetes.

D. Bandyopadhyay, H. Patel, Suresh R. Giri, 2021, Bioorganic & medicinal chemistry.

Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells.

R. Kumar, R. Santen, D. Bandyopadhyay, 1998, Endocrinology.

Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK)

Mahitosh Mandal, M. Mandal, Rakesh Kumar, 1998, Oncogene.

Identification of a novel orally bioavailable NLRP3 inflammasome inhibitor

D. Bandyopadhyay, Rajiv Sharma, Mukul R Jain, 2020, Bioorganic & Medicinal Chemistry Letters.

Physical Interaction between Epidermal Growth Factor Receptor and DNA-dependent Protein Kinase in Mammalian Cells*

M. Mandal, J. Mendelsohn, Rakesh Kumar, 1998, The Journal of Biological Chemistry.

Interferon-alpha signaling promotes nucleus-to-cytoplasmic redistribution of p95Vav, and formation of a multisubunit complex involving Vav, Ku80, and Tyk2.

R. Kumar, D. Bandyopadhyay, L. Adam, 2000, Biochemical and biophysical research communications.

Discovery of N-Cyano-sulfoximineurea Derivatives as Potent and Orally Bioavailable NLRP3 Inflammasome Inhibitors.

D. Bandyopadhyay, Rajiv Sharma, P. Iyer, 2020, ACS medicinal chemistry letters.

Scientific and Regulatory Considerations in the Development of in Vitro Techniques for Toxicology

D. Bandyopadhyay, Mukul R Jain, Rajesh S Sundar, 2018 .

Insulin-induced mitogen-activated protein (MAP) kinase phosphatase-1 (MKP-1) attenuates insulin-stimulated MAP kinase activity: a mechanism for the feedback inhibition of insulin signaling.

D. Bandyopadhyay, J. Kusari, A. Kusari, 1997, Molecular endocrinology.

Insulin-induced mitogen-activated protein (MAP) kinase phosphatase-1 (MKP-1) attenuates insulin-stimulated MAP kinase activity

D. Bandyopadhyay, J. Kusari, A. Kusari, 1997 .

Estrogen Receptor Expression and Function in Long-Term Estrogen-Deprived Human Breast Cancer Cells* * This work was supported by Grants NIH-RO-1-65622-04 (to R.J.S.), HD-25719 (to M.A.S.), GM-55985 and CA-44579 (to T.P.B.), and CA-65746 (to R.K.).

Rakesh Kumar, R. Santen, D. Bandyopadhyay, 1998, Endocrinology.

Optimisation of momelotinib with improved potency and efficacy as pan-JAK inhibitor.

D. Bandyopadhyay, Mukul R Jain, P. Giri, 2022, Bioorganic & Medicinal Chemistry Letters.

Syntheses, biological evaluation of some novel substituted benzoic acid derivatives bearing hydrazone as linker

D. Bandyopadhyay, Mukul R Jain, Rajesh Sharma, 2021, Research on Chemical Intermediates.

Rakesh Kumar, R. Santen, D. Bandyopadhyay, 1998, Endocrinology.

Design, synthesis and biological evaluation of novel pyrazolo-pyrimidin-amines as potent and selective BTK inhibitors.

D. Bandyopadhyay, Mukul R Jain, P. Jadav, 2022, Bioorganic chemistry.

Identification of an Orally Efficacious GPR40/FFAR1 Receptor Agonist.

D. Bandyopadhyay, Suresh R. Giri, Mukul R Jain, 2016, ACS medicinal chemistry letters.